Challenges in the Evaluation of Nanoscale Research: Ethical Aspects

Altmann J (2005) Nanotechnology and preventive arms control. Stiftung Friedensforschung (DSF), Osnabrück (also available electronically) Altmann J (2006) Military nanotechnology: potential application and preventive arms control. Routledge, London Beauchamp TL, Childress JF (2001) Principles of biomedical ethics. 5th ed. Oxford University Press, New York Bender W, Hauskeller C, Manzei A (eds) (2005) Crossing borders. Cultural, religious and political differences concerning stem cell research. Agenda, Münster Beyleveld D (1991) The dialectical necessity of morality: an analysis and defense of Alan Gewirth’s argument to the principle of generic consistency. University of Chicago Press, Chicago Bolt I, Wijsbek H, de Beaufort I, Hilhorst M (2002) Beauty and the doctor: moral issues in health care with regard to appearances. Damon, Rotterdam, Brussels Borm PJ, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, Schins R, Stone V, Kreyling W, Lademann J, Krutman J, Warheit D, Oberdorster E (2006) The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol 3:11(Aug 14) Callon M, Law J, Rip A (eds) (1986) Mapping the dynamics of science and technology: sociology of science in the real world. Macmillan, Basingstoke Duncan R (2004) Nanomedicines in action. Pharm J 273:485–488 (Oct 2) EGE (European Group on Ethics in Science and New Technologies to the European Commission) (2007) Opinion on the ethical aspects of nanomedicine. Opinion no. 21, January 17, European Commission, Brussels. Available electronically at http://ec.europa.eu/european_group_ethics/index_en.htm Egonsson D (1998) Dimensions of dignity: the moral importance of being human. Kluwer, Dordrecht Ferrari M (2005a) Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5(3):161–171 Ferrari M (2005b) Nanovector therapeutics. Curr Opin Chem Biol 9(4):343–346 Fleischhauer K, Hermerén G (2006) Goals of medicine in the course of history and today. Kungl. Vitterhets Historie och Antikvitets Akademien Almqvist & Wiksell distr, Stockholm Freitas R (1998–2006) Nanomedicine. Available at: http://www.foresight.org/nanomedicine, accessed March 26, 2007 Fuchs M, Lanzerath D, Hillebrand I, Runkel T, Balcerak M, Schmitz B (2002) Enhancement. Die etische Diskussion über biomedizinische Verbesserungen des Menschen. DRZE Sachstandsbericht Number 1, Bonn Gewirth A (1978) Reason and morality. University of Chicago Press, Chicago Gewirth A (1982) Human rights: essays on justification and applications. University of Chicago Press, Chicago Gewirth A (1996) The community of rights. University of Chicago Press, Chicago Global Forum for Health Research (2004) 10/90 report on health research 2003–2004. Published on 10 May 2004, Geneva. Available at: http://www.globalforumhealth.org Hermerén G (1977) Criteria of Objectivity in History. Dan Yearb Philos 14:13–40 Hermerén G (1996) Kunskapens pris (The price of knowledge/In praise of knowledge), 2nd edn. Swedish Academic, Stockholm Hermerén G (2006) European values, ethics and law. Present policies and future challenges. Jahrb Wiss Ethik 11:5–40 Holland S, Lebacqz K, Zoloth L (2001) The human embryonic stem cell debate. MIT, Cambridge, MA International Risk Governance Council (2006) Nanotechnology risk governance. IRGC June, Geneva Loue S (2000) Textbook of research ethics: theory and practice. Plenum, New York Mason RO, Mitroff II (1981) Challenging strategic planning assumptions: theory, cases and techniques. Wiley, New York Mitroff II (1983) Stakeholders of the organizational mind. Jossey-Bass, San Fransisco Murphy TF (2004) Case studies in biomedical research ethics. MIT, Cambridge, MA Oberdörster G, Oberdörster E, Oberdörster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113(7):823–839 Phillips R (2003) Stakeholder theory and organizational ethics. Berrett-Koehler, San Fransisco Rawls J (1999) A theory of justice, revised edition. Oxford University Press, Oxford Rip A, Misa TJ, Schot J (eds) (1995) In: Managing technology in society: the approach of constructive technology assessment. Pinter, London Rodemeyer M, Sarewitz D, Wilsdon J (2005) The future of technology assessment. Woodrow Wilson Center, Washington, DC Royal Society and Royal Academy of Engineering (2004) Nanoscience and nanotechnologies: opportunities and uncertainties. Royal Society and Royal Academy of Engineering, London SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks) (2005) The appropriateness of existing methodologies to assess the potential risks associated with engineered and adventitious products of nanotechnologies. No. 29.9 Singer P (ed) (1993) A companion to ethics. Basil Blackwell, Oxford Smalley R (2001) Of chemistry, love and nanobots – how soon will we see the nanometer-scale robots envisaged by K. Eric Drexler and other molecular nanotechnologists? The simple answer is never. Sci Am 285:68–69 Smalley R (2003) Presentation to the President’s Council of Advisors on Science and Technology, March 3, 2003. Available at: http://www.ostp.gov/PCAST/march3meetingagenda.html WHO (2002) World Health Report. Reducing risks, promoting healthy life. World Health Organization, Geneva